Israeli company emerges from stealth with seed funding touting “the next revolution in precision oncology”, powered by its ENLIGHT platform, designed to predict responses to therapies for dozens of cancers.
Israeli company emerges from stealth with seed funding touting “the next revolution in precision oncology”, powered by its ENLIGHT platform, designed to predict responses to therapies for dozens of cancers.